DK631387D0 - viral vector - Google Patents

viral vector

Info

Publication number
DK631387D0
DK631387D0 DK631387A DK631387A DK631387D0 DK 631387 D0 DK631387 D0 DK 631387D0 DK 631387 A DK631387 A DK 631387A DK 631387 A DK631387 A DK 631387A DK 631387 D0 DK631387 D0 DK 631387D0
Authority
DK
Denmark
Prior art keywords
protein
viral vector
gene coding
vector
gene
Prior art date
Application number
DK631387A
Other languages
Danish (da)
Other versions
DK631387A (en
Inventor
Marc Girard
Luc Montagnier
Guy Rautmann
Jean-Pierre Lecocq
Marie-Paule Kieny
Jean-Claude Gluckmann
Patrick Salmon
Original Assignee
Transgene Sa
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa, Pasteur Institut filed Critical Transgene Sa
Publication of DK631387D0 publication Critical patent/DK631387D0/en
Publication of DK631387A publication Critical patent/DK631387A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Viral vector comprising at least: - a part of the genome of a vector virus, - the complete gag gene or one of its subfragments, especially a gene coding for the p25 protein or a gene coding for the p18 protein of the HIV virus responsible for AIDS, - and the elements ensuring the expression of this protein in eukaryote cells in a culture.
DK631387A 1986-12-01 1987-12-01 viral vector DK631387A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8616787A FR2607518B1 (en) 1986-12-01 1986-12-01 VIRAL VECTOR AND RECOMBINANT DNA ENCODING PROTEIN P25 OF THE VIRUS CAUSAL AGENT OF THE S.I.D.A., INFECTED CELL CULTURE, PROTEIN OBTAINED, VACCINE AND ANTIBODIES OBTAINED

Publications (2)

Publication Number Publication Date
DK631387D0 true DK631387D0 (en) 1987-12-01
DK631387A DK631387A (en) 1988-06-02

Family

ID=9341436

Family Applications (1)

Application Number Title Priority Date Filing Date
DK631387A DK631387A (en) 1986-12-01 1987-12-01 viral vector

Country Status (9)

Country Link
EP (1) EP0276591B1 (en)
JP (1) JPS63254983A (en)
KR (1) KR880007728A (en)
AT (1) ATE103934T1 (en)
AU (1) AU604791B2 (en)
DE (1) DE3789545T2 (en)
DK (1) DK631387A (en)
FR (1) FR2607518B1 (en)
PT (1) PT86234B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2617715B1 (en) * 1987-07-07 1990-08-31 Transgene Sa VIRAL VECTOR AND RECOMBINANT DNA ENCODING FOR ONE OR MORE SURFACE PROTEINS (HA AND / OR F) OF A MORBILLIVIRUS, INFECTED CELL CULTURE, PROTEINS OBTAINED, VACCINE AND ANTIBODIES OBTAINED
DE68921034D1 (en) * 1988-09-27 1995-03-23 Dana Farber Cancer Inst Inc Vector containing a replication-competent HIV-I provirus and a heterologous gene.
FR2640877A1 (en) * 1988-12-06 1990-06-29 Centre Nat Rech Scient
US5232829A (en) * 1989-09-29 1993-08-03 Hoffmann-La Roche Inc. Detection of chlamydia trachomatis by polymerase chain reaction using biotin labelled lina primers and capture probes
JP2002125687A (en) * 2000-10-30 2002-05-08 Tosoh Corp Oligonucleotide for detecting hiv-1 and method for detecting the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR860915B (en) * 1985-04-08 1986-07-11 Genetic Systems Corp Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to lav

Also Published As

Publication number Publication date
EP0276591B1 (en) 1994-04-06
DE3789545T2 (en) 1994-08-25
PT86234B (en) 1990-11-07
DK631387A (en) 1988-06-02
EP0276591A3 (en) 1988-10-05
JPS63254983A (en) 1988-10-21
FR2607518A1 (en) 1988-06-03
PT86234A (en) 1987-12-01
AU604791B2 (en) 1991-01-03
FR2607518B1 (en) 1989-10-20
ATE103934T1 (en) 1994-04-15
EP0276591A2 (en) 1988-08-03
KR880007728A (en) 1988-08-29
DE3789545D1 (en) 1994-05-11
AU8188187A (en) 1988-06-02

Similar Documents

Publication Publication Date Title
ATE520783T1 (en) LENTIVIRAL VECTORS
ATE366314T1 (en) INFECTIOUS RNA VIRUS CLONES, VACCINES AND DERIVED DIAGNOSTIC ASSAY
GR3034708T3 (en) Retrovirus of the type HIV-2 capable of inducing AIDS, and the antigenic and nucleic acid components thereof.
KR960001819B1 (en) Viral vector coding for a glycoprotein of the virus responsible
ES2194029T3 (en) VIRUS VARIATIONS HIV-2.
DK631387D0 (en) viral vector
DK637988D0 (en) RECOMBINANT POLYPEPTIDES
PT975783E (en) "RETROVIRAL VECTORS, PROCESS FOR ITS PRODUCTION AND ITS USE FOR THE TRANSFER OF GENES TO CD4-POSITIVE CELLS"
AU7514087A (en) Vaccine containing the protein f of the aids virus
DK498387A (en) Viral DNA SEQUENCE
DK0880594T3 (en) Retroviral vector and its use in gene therapy
AP1561A (en) Use of non-cytolytic retrovirus as vaccines for the treatment of HIV infection.
NO872777L (en) AIDS virus gene expression.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment